Xanthine oxidase inhibitor and therapeutic treatment using same
    1.
    发明授权
    Xanthine oxidase inhibitor and therapeutic treatment using same 失效
    黄嘌呤氧化酶抑制剂及其治疗方法

    公开(公告)号:US4305942A

    公开(公告)日:1981-12-15

    申请号:US201500

    申请日:1980-10-28

    CPC分类号: C07D487/04 A61K31/00

    摘要: Therapeutic xanthine oxidase inhibitor composition containing as an active ingredient 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine dihydrate of the formula ##STR1## Uratic diathesis in warm-blooded animals is therapeutically treated by administering the aforementioned xanthine oxidase inhibitor to such animals, e.g., human, either orally or by means of an injection, thereby inhibiting their xanthine oxidase activity.

    摘要翻译: 含有下式的作为活性成分的3-二甲基氨基-7-甲基-1,2-(正丙基丙二酰基)-1,2-二氢-1,2,4-苯并三嗪二水合物的治疗性黄嘌呤氧化酶抑制剂组合物 通过以口服或注射方式向这些动物例如人类施用上述黄嘌呤氧化酶抑制剂来治疗温血动物的素质,由此抑制其黄嘌呤氧化酶活性。